loader
Please Wait
Applying Filters...

List of Apremilast Active Pharmaceutical Ingredient (API) suppliers/manufacturers & exporters

Client Email Product
Left Arrow
Right Arrow
Filters Filter

Virtual Booth European generic drug manufacturer/ API Supplier/ 6 manufacturing sites/ 5 R&D Centers/ 700 products & 250 under development.

Polpharma is a modern international pharmaceutical company that started its activity in the domestic Polish market and has become one of the top 20 generic drug manufacturers in the world. Today Polpharma employs nearly 7500 people and has 6 manufacturing sites in Poland, Russia and Kazakhstan, as well as 5 Research and Development centers. We manu...
Polpharma is a modern international pharmaceutical company that started its activity in the domestic Polish market and has become one of the top 20 generic drug manufacturers in the world. Today Polpharma employs nearly 7500 people and has 6 manufacturing sites in Poland, Russia and Kazakhstan, as well as 5 Research and Development centers. We manufacture prescription-only medicines and medicines restricted to hospital use, OTC medicines, food supplements and medical devices. Our principal domains are cardiovascular, gastrointestinal, neurological, respiratory, anti-infectious, dermatological and ophthalmic drugs.
Polpharma-Company-Banner

CPhI Middle East & Africa

Booth No. K52

Request a Meeting Now

Virtual Booth Offering Full Spectrum of services from early stage of synthesizing potential NCE's to Large-Scale Commercial Operation.

ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry.Combining co...
ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a wide portfolio of services ranging from custom synthesis for early phase pharmaceutical activities to brand companies as well as APIs for the generic industry.Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector.
Scino-Pharm-Company-Banner

CPhI Worldwide

Booth No. 40C20

Request a Meeting Now

Virtual Booth Trusted API partner since 2002, supplying High-Quality products to Pharmaceutical Companies in Regulated Markets.

Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method development. Tecoland provides high quality APIs to the pharmaceutical industry, with reliable technical and regulatory support such as USDMF, CEP, EDMF that are critical to the sp...
Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method development. Tecoland provides high quality APIs to the pharmaceutical industry, with reliable technical and regulatory support such as USDMF, CEP, EDMF that are critical to the speedy approval of our customers’ regulatory filings.
Tecoland-Company-Banner

CPhI Worldwide

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Lewens Labs finds its roots in 4 years of engineering during which we saw a dream to carve out a niche for ourselves in Pharmaceutical Industry. As a part of the final year project, We worked on cost reduction of “Aceclofenac” which fetched us four national awards including one from Consultancy Development Center, Government of India. At Lewens...
Lewens Labs finds its roots in 4 years of engineering during which we saw a dream to carve out a niche for ourselves in Pharmaceutical Industry. As a part of the final year project, We worked on cost reduction of “Aceclofenac” which fetched us four national awards including one from Consultancy Development Center, Government of India. At Lewens, We aim to develop and provide quality,cost effective and sustainable solutions to our Customers by empowering people to think beyond the traditional norms of Chemistry and Engineering to come up with different and innovative solutions to the problems.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and ma...
More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, and starts business activities trading with pharmaceutical raw materials. In the 80's, the company expanded its operations into the Industrial Business, developing and manufacturing active pharmaceutical ingredients (APIs) in Italy (Industriale Chimica) and in Spain (Quimica Sintetica). In the 90's, CHEMO starts developing and manufacturing high quality and technology finished dosage forms (FDFs).

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Huapont is a fast-growing listed pharmaceutical company manufacturing and marketing Active Pharmaceutical Ingredients (APIs) as well as finished dosages to the domestic and international market. Huapont, established in 1992, is equipped with state-of-the-art facilities and strong R&D force. It is mainly dedicated to the manufacturing and marketing...
Huapont is a fast-growing listed pharmaceutical company manufacturing and marketing Active Pharmaceutical Ingredients (APIs) as well as finished dosages to the domestic and international market. Huapont, established in 1992, is equipped with state-of-the-art facilities and strong R&D force. It is mainly dedicated to the manufacturing and marketing of APIs and drug products of dermatology, anti-tuberculosis and oncology. The company is especially focused on its core skills in the research and development of retinoic acids series products, and it can provide the largest varieties of retinoic acids product in China, accounting for over 56% market share of China retinoic acids market by value. In 2005, Huapont merged and acquired Shaanxi Hanjiang Pharmaceutical Group Co., Ltd. (hereinafter called "Hanjiang Pharmaceutical" ), and takes it as the API exporting base. Hanjiang Pharmaceutical is an US-cGMP compliant pharmaceutical enterprise ranking among the largest manufacturers for drug substances of anthelmintic in China. This company is not only COS acquired for several products, but also US-FDA inspected and approved. A cGMP-compliance manufacturing plant was established in Hanjiang Pharmaceutical in the 1980s, and a stable and close relationship between them has been formed.Hanjiang Pharmaceutical became an API supplier for Janssen Pharmaceutical Belgium, and receives the annual audit performed by Janssen since it first passed the GMP audit by Janssen in 1992. This acquisition allows Huapont to combine its own R&D strength with the cGMP advantage and production capability of Hanjiang Pharmaceutical, which greatly enhanced the competence of the company as an API supplier for the international market. Huapont is capable of offering a wide range of products and services to companies involved in pharmaceutical, veterinary, nutraceutical, cosmetic, specialty chemicals, and other industries. And our resources are ready to deal with such items as designing, developing and optimizing synthetic routes, producing and/or scaling up intermediates and APIs, process development, process validation, or commercial manufacturing for you. In order to improve the production capacity and quality, Chongqing Huapont Pharm.CO.,LTD established a new APIs plant named Chongqing Huapont Shengchem Pharm.CO.,LTD in 2007, it is a subcompany of Chongqing Huapont Pharm.CO.,LTD.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the co...
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds. To the medical fraternity, caring means the assurance of world-class medicines and support across multiple therapeutic areas. For business partners, caring brings the confidence of always getting world-class quality and competitive prices. For employees, caring manifests itself in a safe, equal-opportunities' workplace that fosters innovation for a healthier world.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the co...
Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds. To the medical fraternity, caring means the assurance of world-class medicines and support across multiple therapeutic areas. For business partners, caring brings the confidence of always getting world-class quality and competitive prices. For employees, caring manifests itself in a safe, equal-opportunities' workplace that fosters innovation for a healthier world.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factori...
In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company specialization is full-cycle production of finished dosage forms products for endocrinology, cardiology, rheumatology, ophthalmology and respiratory diseases; including anes...
Farmak International is a leading GMP EU certified pharmaceutical manufacturer in Ukraine established in 1925 with FDA inspected site for production of food supplement. Company specialization is full-cycle production of finished dosage forms products for endocrinology, cardiology, rheumatology, ophthalmology and respiratory diseases; including anesthetics and radiopaque contrast media. Thanks to a strong research base and substantial investments in its production facilities, Farmak International possesses a considerable portfolio of high quality products and is open to cooperation, including but not limited to private labeling, in- and out-licensing, technologies transfers, R&D and contract manufacturing.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Hangzhou Longshine Bio-Tech CO., Ltd started in 2011, locating in Hangzhou, Zhejiang, China. We specially focus on servicing pharmaceutical and chemical goods, both export & Import. The Team includes Master of Biology, Chemists, pharmacists, and etc.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical intermediates and new drugs. The company is mainly engaged in customized synthesis of complex small molecule frameworks and pharmaceutical intermediates, and independent R&D of...
Haoyuan Chemexpress Co., Ltd., located in Shanghai Zhangjiang Biomedical Base, is a high-tech company specializing in customized chemical synthesis and R&D of pharmaceutical intermediates and new drugs. The company is mainly engaged in customized synthesis of complex small molecule frameworks and pharmaceutical intermediates, and independent R&D of innovative new drugs; and provides services of production technology improvement and consigned new drug development for pharmaceutical enterprises. Haoyuan Chemexpress is committed to researching and developing APIs and pharmaceutical intermediates with high synthesis technology barriers and difficulties and high added value, and also focuses on the synthesis of chiral compounds.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offe...
Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization. Hetero is a leading international supplier with a rich portfolio of over 200 products from wide range of therapeutic categories both in active pharmaceutical ingredients and finished dosages. Hetero’s manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. Majority of them are approved by the various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish agency of medicines & health care products, ANVISA-Brazil, IDA-Netherlands etc., With full-fledged marketing capabilities, the company has been able to market its products in over 138 countries across the globe.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Laxmidas Dahyabhai & Co. (LDCO) was established in the year 1928. Appointed as a distributor for few Ayurvedic companies to cater to South Mumbai, today we are a distributor for more than 200 companies with branches plying the entire Mumbai city area. We deliver more than 10000 products to over 4500 retailers. A new portfolio of Bulk Drugs has been...
Laxmidas Dahyabhai & Co. (LDCO) was established in the year 1928. Appointed as a distributor for few Ayurvedic companies to cater to South Mumbai, today we are a distributor for more than 200 companies with branches plying the entire Mumbai city area. We deliver more than 10000 products to over 4500 retailers. A new portfolio of Bulk Drugs has been incorporated for international markets serving the Pharmaceutical, Feed, Cosmetic and Food Industry.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

THE TWO MAIN AREAS OF JSC OLAINFARM OPERATION ARE: Manufacturing of oral dosage medicament forms; Manufacturing of chemical ingredients and active pharmaceutical ingredients. THE RANGE OF PRODUCTS MANUFACTURED BY JSC OLAINFARM INCLUDE: 7 original products: Bikarfen, Etacizin, Noofen, Fenkarol, Furagin, Neiromidin, Adaptol; 26 non-proprietary (gener...
THE TWO MAIN AREAS OF JSC OLAINFARM OPERATION ARE: Manufacturing of oral dosage medicament forms; Manufacturing of chemical ingredients and active pharmaceutical ingredients. THE RANGE OF PRODUCTS MANUFACTURED BY JSC OLAINFARM INCLUDE: 7 original products: Bikarfen, Etacizin, Noofen, Fenkarol, Furagin, Neiromidin, Adaptol; 26 non-proprietary (generic) medicaments; More than 25 active pharmaceutical ingredients. Joint stock company Olainfarm is one of the largest companies in the Baltic States with more than 40 years of experience in production of medicaments and chemical pharmaceutical products. The key principle of the Company is manufacturing of reliable and effective high quality products to the whole world. Products of JSC Olainfarm are exported to more than 35 countries, including the Baltic States, Russia, other CIS countries, Scandinavian, Western European and Asian countries, as well as North America and Australia. The Company was founded in 1972 as state enterprise “Olaines ķīmiski – farmaceitiskā rūpnīca” (Olaine Chemical-Pharmaceutical Plant). The main goal of founding the Company was to ensure pharmaceutical substances and semiproducts to several finished drug form manufacturing plants in the Soviet Union. As a result of privatization in 1997, the Company was reorganized into a joint stock company and its shares were listed on stock exchange. Starting from 1 December 2006, shares of JSC Olainfarm are listed in the Main List of stock exchange NASDAQ OMX Riga. Currently, more than highly qualified experts are employed by JSC Olainfarm in Latvia. The Company is equipped with advanced technologies and is certified according to the requirements of Good Management Practice (GMP) of the European Union, Environmental Management Standard ISO 14001:2004. Proof of the high quality of the Company’s products is cooperation with global and regionally acknowledged companies as Novartis, Ranbaxy, Glenmark Generics, Cobalt, Almirall Ranke, UQUIFA, MIAT, Aspen AU, Loba, PHF and many others.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Omgene is a diligent, focussed, and target oriented organization aspiring to be an inspiring presence in the pharmaceutical space. Our core objective is to build a healthier world. The platform of our performance and success is our vision to be a biopharmaceutical company with a special niche in global peptide scenario, delivering on our promise to...
Omgene is a diligent, focussed, and target oriented organization aspiring to be an inspiring presence in the pharmaceutical space. Our core objective is to build a healthier world. The platform of our performance and success is our vision to be a biopharmaceutical company with a special niche in global peptide scenario, delivering on our promise to our patients, clients, investors, and our employees.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Srini is a US-FDA and TGA approved pharmaceutical company located near Hyderabad, South India. We at Srini are actively engaged in the exports of Active Pharmaceutical Ingredients (APIs) and (N-1) drug intermediates to Regulatory and Non-Regulatory markets. The facility has five full-fledged production blocks with the efficient utilities such a...
Srini is a US-FDA and TGA approved pharmaceutical company located near Hyderabad, South India. We at Srini are actively engaged in the exports of Active Pharmaceutical Ingredients (APIs) and (N-1) drug intermediates to Regulatory and Non-Regulatory markets. The facility has five full-fledged production blocks with the efficient utilities such as steam, chilled water, nitrogen generation, cooling water, vacuum and compressed air supply. It has state-of-the-art centralized quality control and R&D Lab. The total capacity of the plant is 276 KL with Ten independent class 100,000 clean room areas to produce 360MT of APIs and 640MT of Intermediates per annum.

Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 empl...
Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

PharmaCompass >>

First
Previous
Next
Last